Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

REDWOOD CITY, Calif. — Directors are selling Xenoport (biopharmaceuticals) too cheaply through an unfair process to Arbor Pharmaceuticals, for $7.03 a share or $467 million, shareholders say in San Mateo County Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...